Ulta Beauty
ULTA
$659.08
-0.80%
Ulta Beauty is the largest specialized beauty retailer in the United States, operating more than 1,500 stores plus an e-commerce platform that together sell cosmetics (38% of 2025 sales), skin care (24%), hair care (19%), and fragrances (13%), supplemented by in-store salon services that generate roughly 4% of revenue and drive traffic; internationally it owns the UK/Ireland-based Space NK chain (86 stores), franchises in Mexico, and runs a Middle East joint venture. Its competitive identity rests on a differentiated 'one-stop beauty destination' model that spans mass-to-prestige price points under one roof — a structure mass merchants and pure-play prestige retailers cannot easily replicate — reinforced by the Ulta Beauty Rewards loyalty program that underpins repeat purchase frequency. The current investor narrative centers on a re-acceleration story: after a difficult 2025 marked by margin pressure and cost concerns that dragged the stock down despite earnings beats, Ulta has posted consecutive Q1 and Q2 2026 beats (Q2 revenue up 8.87% year-over-year to $3.04 billion), raised full-year profit guidance, and seen the shares surge to new highs on improving consumer demand and operating leverage. Debate now hinges on whether this momentum is durable into a potentially stagflationary macro backdrop, whether gross margin can hold near 39% as mix shifts and costs rise, and whether the stock's re-rating has run ahead of fundamentals after a roughly 26% one-year gain.…
ULTA
Ulta Beauty
$659.08
Related headlines
Investment Opinion: Should I buy ULTA Today?
Rating: Hold with a Buy bias on pullbacks. Ulta is a high-quality franchise — 41.14% ROE, 39.1% gross margin, $1.067 billion TTM free cash flow, and a re-accelerating top line (Q2 2026 revenue +8.87% to $3.036 billion after Q1's +11.1%) — but at $644.76 the stock already trades above the $635.84 average analyst target (-1.4% implied downside) and at 25.17x trailing earnings, the top of its 12.1x-25.2x historical band. The core thesis is that the business is executing well but the entry price has absorbed most of the near-term good news after an 18.20% one-month surge.
The supporting evidence is genuinely strong: the forward PE of 20.09x on a consensus EPS estimate of $44.40 implies roughly 25% earnings growth, which would mechanically de-rate the stock without a price decline; ROE of 41.14% and ROA of 14.84% reflect an asset-light, high-turn model with modest leverage (debt-to-equity 0.778); TTM FCF of $1.067 billion funded $805.1 million of buybacks in H1 2026 alone; and the 19 Buy / 8 Hold / 1 Sell split with a 1.82 recommendation mean confirms broad institutional conviction, reinforced by Wells Fargo's September upgrade to Equal Weight and reiterated Buys from Jefferies, Goldman, BofA, UBS and Barclays. Relative strength of +23.19 versus SPY over one month with a beta of just 0.838 shows the market is treating ULTA as a defensive growth haven.
The risks that could invalidate the thesis are margin flattening (Q2 gross margin 39.1% versus 39.2% a year ago and 40.07% in Q1), sequential growth deceleration (8.87% in Q2 from 11.1% in Q1 and 11.8% in Q4 2025), and lumpy cash conversion (Q2 FCF of only $38.4 million after a $345.6 million working-capital drain). This Hold would upgrade to Buy if the stock pulls back toward the $600 round number or the $565 August breakout zone — roughly 7-12% below current levels — or if Q3 confirms high-single-digit growth with gross margin holding at or above 39%. It would downgrade to Sell if revenue growth falls below high-single digits or gross margin slips materially, which would compress the multiple toward 18-20x and point to the $500 analyst low. Verdict: fairly valued to modestly overvalued relative to its own history, but reasonably priced on forward earnings relative to quality — a good business at a full price.
Sign up to view all
ULTA 12-Month Price Forecast
Ulta's fundamentals justify owning the business but not chasing the stock at $644.76. Two consecutive beats, a raised outlook, 8.87% revenue growth, 41.14% ROE and $1.067 billion of TTM free cash flow support the re-acceleration narrative, and the 20.09x forward multiple is defensible for this quality. However, the trailing 25.17x sits at the top of the 12.1x-25.2x historical band, the price has already passed the $635.84 consensus target, and gross margin is flat year-over-year at 39.1% with no expansion room. The 25% bull / 50% base / 25% bear weighting reflects a balanced setup where earnings growth, not multiple expansion, must do the work. I would upgrade to bullish on a pullback toward $600-$565 or on a Q3 print showing growth re-accelerating above 9% with margin holding; I would downgrade to bearish if growth falls below high-single digits or gross margin breaks below 39%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $635.84 and implied upside of -3.5% versus the current price.
Average Target
$635.84
28 analysts
Implied Upside
-3.5%
vs. current price
Analyst Count
28
covering this stock
Price Range
$500 - $731
Analyst target range
Coverage is deep and broadly constructive, with 25 analysts publishing ratings split 19 Buy, 8 Hold, and 1 Sell, yielding a consensus recommendation of 'buy' and a recommendation mean of 1.82 (where 1.0 is a strong buy). The average target price of $635.84 sits slightly below the current $644.76, implying roughly -1.4% downside to consensus — a notable signal that after the recent 18.20% one-month surge, the stock has run past the average analyst's fair value estimate, suggesting the market is front-running upgrades or that targets are stale relative to the momentum. The consensus leans bullish on ratings but neutral-to-cautious on price, a classic setup where analysts like the business but see limited near-term upside after the rally. The target range spans $500 to $731, a wide 46% spread that signals meaningful disagreement about the durability of the growth re-acceleration. The high target of $731 (about 13.4% above the current price) assumes continued earnings beats, multiple expansion toward the upper end of the historical band, and successful margin defense in a tough consumer environment — essentially the 'growth re-rating' scenario. The low target of $500 (roughly 22.5% below current) prices in margin compression, a consumer slowdown, and multiple contraction back toward the 18-20x range, consistent with the stagflation fears flagged in March 2026 macro commentary. Institutional rating flow is mildly positive: Wells Fargo upgraded to Equal Weight from Underweight in September 2026, and Jefferies, DA Davidson, Goldman Sachs, BofA, UBS, Barclays, and Deutsche Bank have all reiterated Buy/Overweight ratings through the August-October window, with Citigroup the lone persistent Neutral — a pattern of steady conviction rather than aggressive upgrades, which fits the 'good business, fully valued' consensus.
Bulls vs Bears: ULTA Investment Factors
The bull case currently has stronger evidence: two consecutive beats, a raised outlook, 8.87% revenue growth, 41.1% ROE, $1.067 billion TTM free cash flow, and a forward PE of 20.09x that is reasonable for the quality on offer. The bear case is not about the business but about the price — the stock trades at 25.17x trailing earnings, the top of its historical band, and above the $635.84 consensus target after an 18.20% one-month surge that has outrun the broader market by 23.19 points. The single most important tension is whether the re-acceleration is durable into a stagflationary backdrop: if Q3 confirms high-single-digit growth and 39% gross margin holds, the forward multiple is defensible and the $731 high target comes into play; if growth decelerates below high-single digits or margin slips, the multiple compresses toward 18-20x and the $500 low target becomes the reference point. Analyst ratings (19 Buy, 8 Hold, 1 Sell, mean 1.82) lean constructive, but the -1.4% implied downside to consensus captures the 'good business, fully valued' standoff. Net-net, the fundamentals support owning the stock; the entry price argues for patience.
Bullish
- Earnings re-acceleration confirmed by beats: Ulta has now posted consecutive Q1 and Q2 2026 beats, with Q2 revenue of $3.036 billion up 8.87% year-over-year versus $2.788 billion a year earlier, and Q1 2026 revenue of $3.164 billion up 11.1% from $2.848 billion. The Q1 print also came with a raised full-year profit outlook, signaling management confidence in the demand backdrop. This marks a clear inflection from the prior-year stagnation when Q2 2025 grew only about 2.6%.
- Forward PE de-rating on 25% EPS growth: The trailing PE of 25.17x falls to a forward PE of 20.09x, implying roughly 25% earnings growth over the next twelve months against a consensus EPS estimate of $44.40. That forward multiple is a far more comfortable level for a retailer with a 41.1% ROE and 39.1% gross margin. If the earnings bridge materializes, the stock de-rates mechanically without any price decline.
- Exceptional returns on capital: ROE of 41.14% and ROA of 14.84% reflect a high-turn, asset-light store model with modest leverage (debt-to-equity of 0.778). Free cash flow TTM is $1.067 billion, funding $805.1 million of buybacks across Q1 and Q2 2026 ($557.1 million and $248.0 million respectively). Few specialty retailers combine this margin profile with this cash generation.
- Defensive relative strength in weak tape: ULTA is up 18.20% over one month and 14.09% over three months while SPY fell 4.99% and 4.91% respectively, producing relative strength readings of +23.19 and +19.00. The 1-month gain outrunning the 3-month figure confirms acceleration rather than deceleration. With a beta of 0.838, this outperformance came with roughly 16% less systematic volatility than the market.
Bearish
- Stock has run past consensus target: The average analyst target of $635.84 sits below the current $644.76, implying roughly -1.4% downside to consensus after the 18.20% one-month surge. The market appears to be front-running upgrades or that targets are stale relative to momentum. A 46% spread between the $500 low and $731 high target signals real disagreement about durability.
- Valuation at top of historical PE band: The trailing PE of 25.17x sits at the very top of Ulta's historical range of roughly 12.1x (Q4 2024) to 25.2x (Q3 2025). At this level the market is pricing in optimistic expectations and leaving little room for execution error. Multiple compression toward the 18-20x range would imply 20-25% downside even with earnings intact.
- Gross margin flattening, no expansion room: Q2 2026 gross margin of 39.1% is roughly flat versus 39.2% in Q2 2025 and down from Q1 2026's 40.07%, while operating margin of 12.66% barely expanded from 12.55%. Net margin was essentially stable at 9.29% versus 9.36%. The flattening suggests limited room for further margin expansion without sales leverage, and the Q4 2025 print already showed the market punishing cost and margin concerns despite a beat.
- Growth decelerating sequentially: Q2 2026 revenue growth of 8.87% decelerated from Q1 2026's 11.1% and Q4 2025's 11.8%. The sequential slowdown warrants watching for a potential second-half deceleration, particularly against a stagflationary macro backdrop flagged in March 2026 commentary. Any slip below high-single-digit growth would undercut the re-rating thesis.
ULTA Technical Analysis
ULTA is in a powerful, sustained uptrend that has carried the stock 26.46% over the past year to a current price of $644.76, placing it at approximately 74% of its 52-week range of $443.60 to $714.97. That positioning — well above the midpoint but still about 10% below the 52-week high — signals strong momentum without the extreme overextension that typically precedes sharp mean reversion, and the 36.23% max drawdown on record confirms the stock has already absorbed a violent correction earlier in the cycle. The recovery structure, with higher lows since the spring trough near $450, argues that buyers have consistently defended the trend rather than chasing a single spike. Short-term momentum is decisively accelerating: the stock is up 18.20% in the past month and 14.09% over three months, meaning the bulk of the recent gain is fresh rather than stale. Critically, this sharply diverges from the broader market, with SPY down 4.99% over one month and 4.91% over three months, producing relative strength readings of +23.19 and +19.00 respectively — an extraordinary spread that indicates ULTA is being treated as a defensive growth haven amid macro anxiety. The 1-month surge outrunning the 3-month figure (+18.20% vs. +14.09%) confirms acceleration rather than deceleration, though the modest -0.78% pullback on the latest session after touching $660.70 suggests some near-term profit-taking at the highs. Key resistance sits at the 52-week high of $714.97, roughly 10.9% above the current price; a clean breakout there would confirm a new leg higher and likely trigger momentum-fund inflows, while support is anchored at the $443.60 52-week low, with intermediate support around the $600 round number and the $565 August breakout zone. The beta of 0.838 is a notable positive for risk management — the stock is roughly 16% less volatile than the market, meaning the recent 18% monthly move occurred with below-market systematic risk, and position sizing can be somewhat more generous than for a high-beta name. Volume of roughly 396,308 shares on the latest session is modest and worth monitoring for confirmation on any breakout attempt.
Beta
0.84
0.84x market volatility
Max Drawdown
-36.2%
Largest decline past year
52-Week Range
$444-$715
Price range past year
Annual Return
+26.1%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | +16.1% | -2.4% |
| 3m | +27.8% | -2.3% |
| 6m | +33.3% | +2.8% |
| 1y | +26.1% | +11.3% |
| ytd | +6.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Revenue is re-accelerating on a multi-quarter view: Q2 2026 (period ending 2026-08-01) revenue reached $3.036 billion, up 8.87% year-over-year versus $2.788 billion in Q2 2025, and the sequential cadence shows Q1 2026 at $3.164 billion (up 11.1% from $2.848 billion in Q1 2025) and Q4 2025 at $3.898 billion (up 11.8% from $3.488 billion). This marks a clear inflection from the prior-year stagnation, when Q3 2025 revenue of $2.858 billion grew only 12.9% off a depressed base but Q2 2025's $2.788 billion represented just 2.6% growth over Q2 2024's $2.717 billion-equivalent trajectory — the current run-rate of high-single to low-double-digit growth is a meaningful step up. Segment data shows retail stores at $1.737 billion and e-commerce at $294 million driving the bulk of sales, with salon at $77 million and other segments at $16 million, confirming the store base remains the growth engine even as digital scales. The trajectory supports the bull case that Ulta is taking share in a resilient beauty category, though the 8.87% Q2 growth rate decelerating from Q1's 11.1% warrants watching for a potential slowdown in the second half. Profitability is robust and improving: Q2 2026 net income was $282.0 million on a 39.1% gross margin and 12.5% operating margin, with net margin at 9.31% and diluted EPS of $6.57. The margin trajectory is the key story — gross margin of 39.1% in Q2 2026 compares favorably to 38.1% in Q4 2025 but is roughly flat versus 39.2% in Q2 2025, while operating margin of 12.66% in Q2 2026 expanded from 12.55% a year earlier and net margin rose from 9.36% to 9.29% (essentially stable). The Q1 2026 quarter was the standout with a 40.07% gross margin and 14.17% operating margin, and the sequential compression into Q2 reflects normal seasonality plus cost pressure; the 12.5% operating margin is healthy for specialty retail and consistent with Ulta's historical 12-15% band, but the flattening gross margin suggests limited room for further expansion without sales leverage. Balance sheet and cash flow are solid but show working-capital strain: debt-to-equity is 0.778, the current ratio is 1.41, and ROE is an exceptional 41.14% with ROA of 14.84%, reflecting high asset turnover and modest leverage. Free cash flow TTM is $1.067 billion, though quarterly FCF is lumpy — Q2 2026 generated only $38.4 million as operating cash flow of $119.7 million was consumed by a $345.6 million working-capital drain and $81.3 million of capex, while Q1 2026 produced $203.6 million and Q4 2025 a hefty $907.4 million. The company is aggressively returning capital, repurchasing $248.0 million of stock in Q2 2026 and $557.1 million in Q1 2026, funded comfortably by the full-year cash generation; with no dividend, all shareholder returns flow through buybacks, and the $158.5 million cash balance plus strong internal cash generation means external financing dependence is minimal.
Quarterly Revenue
$3.0B
2026-08
Revenue YoY Growth
+8.9%
YoY Comparison
Gross Margin
39.1%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
Because Ulta is solidly profitable — Q2 2026 net income of $282.0 million and TTM EPS supporting a positive trailing multiple — the PE ratio is the appropriate primary metric, and the trailing PE of 25.17x against a forward PE of 20.09x implies the market expects roughly 25% earnings growth over the next twelve months, consistent with the consensus EPS estimate of $44.40. The gap between trailing and forward multiples is meaningful: it signals investors are paying up today for a projected earnings step-up, and if that growth materializes the stock would de-rate toward 20x, a far more comfortable level for a high-quality retailer. The PEG ratio of 22.87 is distorted by the near-zero reported EPS figure in the metrics feed and should be disregarded in favor of the forward earnings bridge. Against the specialty retail sector, Ulta's 25.17x trailing PE and 2.34x PS sit at a premium to the broader retail average (typically low-to-mid teens on PE), but the premium is defensible given the 41.1% ROE, 39.1% gross margin, and consistent double-digit revenue growth — few retailers combine this margin profile with this growth rate. The EV/EBITDA of 16.79x and EV/Sales of 2.31x are moderate for a category leader with negative net debt dynamics, and the 10.35x price-to-book reflects the asset-light, high-turn store model rather than leverage risk. Historically, Ulta's PE has ranged from roughly 12.1x (Q4 2024) to 25.2x (Q3 2025), and the current 25.17x sits at the very top of that band — the market is pricing in optimistic expectations and leaving little room for execution error. The PS ratio of 2.34x, however, is well below the 7-8x levels recorded in 2025-2026 historical data (which appear to reflect a different share-count basis), so on a sales basis the stock does not look stretched relative to its own history. Net-net, the valuation embeds a growth-recovery thesis: at the top of the PE band, any deceleration in the 8.87% revenue growth or margin slippage would likely trigger multiple compression toward the 18-20x range, implying 20-25% downside risk, while continued beats could support the forward multiple and push shares toward the high end of analyst targets.
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~23x
vs. Industry Avg
29.4x
Industry PE ~29.4x*
EV/EBITDA
16.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin and cash-flow quality rather than solvency. Gross margin of 39.1% in Q2 2026 was flat versus 39.2% a year earlier and down from 40.07% in Q1 2026, while operating margin of 12.66% expanded only 11 basis points year-over-year and net margin was essentially unchanged at 9.29% versus 9.36% — the company is growing revenue without meaningful margin leverage. Cash conversion is lumpy: Q2 2026 free cash flow was just $38.4 million after a $345.6 million working-capital drain and $81.3 million of capex, against $907.4 million in Q4 2025, and the current ratio of 1.41 with $158.5 million of cash offers a thinner buffer than the $1.067 billion TTM FCF headline implies. Revenue is also concentrated in the US store base ($1.737 billion of Q2 retail sales versus $294 million e-commerce), leaving the company exposed to a single consumer and a single channel for the bulk of its earnings. Finally, the $805.1 million of buybacks executed in the first half of 2026 were funded from a seasonal cash peak, so a demand slowdown would force a choice between capital returns and balance-sheet flexibility. Market and competitive risks are dominated by valuation compression. At 25.17x trailing earnings the stock sits at the top of its historical 12.1x-25.2x band, and the average analyst target of $635.84 is already below the $644.76 price, meaning the market has outrun published fair value after an 18.20% one-month move. The 46% spread between the $500 low and $731 high target reflects genuine disagreement about durability, and the lone persistent Neutral (Citigroup) alongside a September Wells Fargo upgrade to Equal Weight from Underweight suggests conviction is steady rather than expanding. Macro sensitivity is real despite a beta of 0.838: March 2026 commentary flagged stagflation fears from sticky inflation and a GDP revision shock, and the Q4 2025 print showed the stock falling despite a beat on cost and margin concerns. Competitive pressure from mass merchants and prestige pure-plays on the beauty category, plus the risk that the 23.19-point one-month relative strength versus SPY reverses as a sector rotation out of defensive growth, rounds out the external threat set. The worst-case scenario is a growth-to-margin negative feedback loop: Q3 revenue growth decelerates below high-single digits, gross margin slips from 39.1% as mix shifts and costs rise, and the market re-rates the stock from 25.17x toward the 18-20x range consistent with the stagflation narrative. That combination would take the shares toward the $500 analyst low target, roughly -22.5% from the current $644.76, and in a deeper consumer slowdown toward the $443.60 52-week low, about -31.2%. The 36.23% max drawdown on record shows this magnitude of decline is not hypothetical — the stock has already absorbed a violent correction earlier in the cycle. An investor buying at today's price should size positions for a realistic -22% to -31% downside in the adverse case, cushioned only modestly by the 0.838 beta and the absence of dividend support.
FAQ
The most severe risk is valuation compression: at 25.17x trailing earnings, the top of the 12.1x-25.2x historical band, a re-rating toward 18-20x would imply 20-25% downside even if earnings hold, and the stock already trades above the $635.84 consensus target. Second is margin stagnation — Q2 2026 gross margin of 39.1% was flat versus 39.2% a year earlier and down from 40.07% in Q1, while operating margin of 12.66% expanded only 11 basis points, leaving little cushion if costs rise. Third is growth deceleration, with revenue growth slowing sequentially from 11.8% (Q4 2025) to 11.1% (Q1 2026) to 8.87% (Q2 2026) into a stagflationary backdrop flagged in March 2026 commentary. Fourth is cash-flow lumpiness and concentration: Q2 free cash flow was just $38.4 million after a $345.6 million working-capital drain, the current ratio is 1.41 with $158.5 million of cash, and the US store base ($1.737 billion of Q2 retail sales versus $294 million e-commerce) concentrates exposure in a single consumer and channel. The 36.23% max drawdown on record shows a -22% to -31% adverse move is not hypothetical.
The 12-month forecast is weighted toward a range-bound base case: 50% probability of $600-$660, centered on the $635.84 average analyst target, where earnings grow into the price rather than the price running ahead of earnings. The bull case carries 25% probability with a $714.97-$731 target range (the 52-week high to the analyst high), requiring Q3 and Q4 revenue growth at or above 9% with gross margin holding near 39% and a breakout above the 52-week high. The bear case carries 25% probability with a $443.60-$500 range (the 52-week low to the analyst low), driven by a stagflationary consumer slowdown, gross margin slipping below 39%, and multiple compression toward 18-20x. The most likely outcome is the base case, whose key assumption is that revenue growth decelerates modestly from 8.87% but stays in high-single digits while gross margin holds in the 39-40% band. Note that the current $644.76 price already sits near the top of the base-case range, so the risk/reward skews slightly negative at today's level.
ULTA looks fairly valued to modestly overvalued on trailing metrics but reasonably priced on forward earnings. The trailing PE of 25.17x is at the very top of the historical 12.1x-25.2x range, while the forward PE of 20.09x on the $44.40 consensus EPS implies roughly 25% earnings growth and would place the stock at a far more comfortable level if delivered. The 2.34x price-to-sales and 16.79x EV/EBITDA are moderate for a category leader with 39.1% gross margins and 41.14% ROE, and the 10.35x price-to-book reflects an asset-light, high-turn store model rather than leverage risk (debt-to-equity 0.778). Against specialty retail peers, the premium is defensible given the margin and growth profile, but the market is clearly paying for the re-acceleration story: the average target of $635.84 is already below the current price, and the 46% spread between the $500 low and $731 high target shows genuine disagreement. The valuation implies the market expects high-single-digit revenue growth and stable margins to persist — any deceleration would likely trigger a re-rating toward 18-20x.
From a risk/reward standpoint ULTA is a good business at a full price rather than a compelling entry. The stock at $644.76 already trades above the $635.84 average analyst target (-1.4% implied downside) after an 18.20% one-month surge, and at 25.17x trailing earnings it sits at the top of its 12.1x-25.2x historical band. The reward case rests on the forward PE of 20.09x against a $44.40 consensus EPS — roughly 25% implied earnings growth — plus 41.14% ROE and $1.067 billion of TTM free cash flow, which would let the stock de-rate mechanically without a price decline. The downside risk is real: multiple compression toward 18-20x would imply 20-25% downside even with earnings intact, and the $500 analyst low target sits 22.5% below the current price. It is a good buy for patient investors with a 12-24 month horizon who accumulate on a pullback toward $600-$565, or after a Q3 print confirming growth at or above high-single digits with gross margin holding near 39%; it is a poor buy for anyone chasing the recent momentum at today's price.
ULTA is better suited to a medium-to-long-term hold than to short-term trading. The business is in a mature-but-re-accelerating growth stage — 1,500+ US stores plus e-commerce and Space NK abroad — with high earnings visibility from a loyalty-driven repeat-purchase model, 41.14% ROE and $1.067 billion of TTM free cash flow, which supports a 12-24 month holding period. The 0.838 beta means roughly 16% less systematic volatility than the market, so the recent 18.20% one-month move came with below-market risk, but the 36.23% max drawdown and 46% analyst target spread show the stock can still swing violently on margin or growth news. There is no dividend (yield 0%, payout ratio 0%), so total return depends entirely on price appreciation and buyback-driven EPS growth, which removes the income cushion that supports longer holds in slower names. A concrete minimum holding period of 12 months is reasonable, aligned to the Q3 2026 and Q4 2026 prints and the holiday beauty season; short-term traders should note the stock is extended after an 18.20% monthly gain and above consensus target, making a pullback toward $600-$565 the more attractive tactical entry.